RMD Open 2019
Predictors of remission in patients with non-radiographic axial spondyloarthritis receiving open-label adalimumab in the ABILITY-3 study.
Related Questions
Is there a certain disease duration or age beyond which you taper immunosuppressive treatments?
New answer by at NIAMS (August 12, 2023)
This is a difficult question to discuss academically, as we will have to accept a definition for “burning out,” which may or may not be synonymous with remission o...